Celljevity
CE
About
Celljevity is a longevity company focused on reversing biological aging through cellular rejuvenation technology and AI-powered health optimization. They offer the Prometheus Therapy, a patented process that restores aged cells to a youthful state without genetic modification, and complement it with a Digital Twin Platform that uses multi-omic data and AI modeling for personalized longevity. The company aims to make these advanced therapies accessible to a broader population.
Key facts
At-a-glance profile data
- Website
- celljevity.com
- Headquarters
- Beverwijk, Netherlands
- Founded
- 2018
- Total funding
- $63M (Series A)
- Business model
- B2C
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jan 2025 | Series A | $63M | - |
Add first review
Frequently asked
How much funding has Celljevity raised?
Celljevity has raised a total of $63M in funding. The most recent round on record is Series A.
What is Celljevity's current status?
Celljevity's current operating status is: Inactive.